Action Agent
Equip field teams with personalized, coordinated activity in real-time
Company profile
Company profile
Aktana is a leading provider of AI-driven customer engagement solutions specifically designed for the life sciences industry. The company empowers pharmaceutical, biotechnology, and medical technology organizations to optimize their interactions with healthcare professionals (HCPs) through intelligent, data-driven insights and omnichannel orchestration. Aktana's platform serves as an intelligence layer that connects commercial strategy with field execution, enabling brand teams, medical affairs, and sales representatives to deliver personalized, contextually relevant engagement at scale. The company's core offering includes three integrated product suites: Strategy Orchestration, which aligns business objectives with AI-driven tactics and provides real-time KPI tracking; Automated Intelligence, which uses machine learning to identify optimal activities and channels for HCP engagement; and Amplified Engagement, which equips field teams with mobile-ready AI insights and next best action recommendations. These solutions are powered by Aktana's proprietary Contextual Intelligence Engine and Omnichannel Data Interface, which analyze engagement patterns, prescribing behaviors, and HCP preferences to generate actionable recommendations. Aktana serves over 350 brands with more than 1,000 deployments across top global life sciences companies. The platform integrates with existing CRM systems and supports the full spectrum of commercial activities, from brand launches and indication expansions to competitive defense and medical education programs. By combining internal data science models with ready-to-use AI capabilities, Aktana enables life sciences teams to work smarter while maintaining compliance and delivering measurable business impact. In January 2026, Aktana was acquired by PharmaForceIQ, a digital orchestration leader in the pharmaceutical industry.
Company description Aktana official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
No clinical focus areas are currently listed.
Cloud Saas · Hybrid deployment with recorded integration context.
Company milestones
Acquired by PharmaForceIQ in January 2026. Named a Leader and Star Performer in Everest Group's 2024 Life Sciences Next-generation Customer Engagement Platforms (CEPs) PEAK Matrix® in November 2024. Serves 350+ brands with 1,000+ deployments across top global life sciences companies.
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
Equip field teams with personalized, coordinated activity in real-time
The AI engine for omnichannel coordination in life sciences
Simplify and automate omnichannel engagement using AI
Make every HCP interaction count with contextualized recommendations and analytics
Create compelling experiences for every HCP by consolidating all engagements
Connect strategies to impact through AI for continuous improvement across all channels
Leverage AI to identify activities and channels that deliver the greatest results
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
No linked records are currently available.
Clinical validation
No linked records are currently available.
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
9 months after roll-out for top-10 biopharma client using Strategy Orchestration
unlocked with NBA Strategy Orchestration
from Aktana high-adopters using Amplified Engagement
directly driven by NBA suggestions with Strategy Orchestration
came from physicians visited by Aktana high-adopters using Automated Intelligence
during indication launch of oncology drug with AI-based HCP segmentation
for customers who never met the rep, reported by field sales in hematology
for reps who used Aktana suggestions over non-user peers
in hospitals detailed by reps who used Aktana suggestions
New team member onboarding and HCP engagement
70-80% open rate for customers who have never met the rep
Hospital detailing effectiveness
2X more monthly sales in hospitals detailed by reps who used Aktana suggestions
Indication launch optimization with AI-based HCP segmentation
+14% sales growth during indication launch of an oncology drug with AI-based HCP segmentation
Improved HCP email engagement through AI alerts
+40% more approved emails to HCPs from Aktana high-adopters
Sales growth through AI-powered HCP engagement
+14% higher sales just 9 months after roll-out
HCP web portal adoption through field engagement
80% HCP web portal registrations came from physicians visited by Aktana high-adopters
05 · Leadership
Leadership profiles and professional links from the current Company record.
Derek Choy
CEO
06 · Company updates
Recent articles published on Aktana's official website.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies using AI for medication optimization, pharmacy automation, drug pricing and access, medication adherence, polypharmacy management, or pharmacy workflow optimization. Includes platforms that help patients access affordable medications, tools that reduce medication errors, and AI systems that optimize drug regimens for complex patients.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.